{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:22:43Z","timestamp":1759580563965},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,20]]},"DOI":"10.1093\/jnci\/djj371","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T21:16:47Z","timestamp":1158700607000},"page":"1263-1265","source":"Crossref","is-referenced-by-count":14,"title":["Idiotype Vaccination in Follicular Lymphoma: Knocking on the Doorway to Cure"],"prefix":"10.1093","volume":"98","author":[{"given":"Dan L.","family":"Longo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,9,20]]},"reference":[{"key":"key\n\t\t\t\t20171012211941_BIB1","doi-asserted-by":"crossref","unstructured":"Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol2004 ; 22 : 4711 \u20136.","DOI":"10.1200\/JCO.2004.04.020"},{"key":"key\n\t\t\t\t20171012211941_BIB2","doi-asserted-by":"crossref","unstructured":"Portlock CS, Rosenberg SA. No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med1979 ; 90 : 10 \u20133.","DOI":"10.7326\/0003-4819-90-1-10"},{"key":"key\n\t\t\t\t20171012211941_BIB3","doi-asserted-by":"crossref","unstructured":"Gattiker HH, Wiltshaw E, Galton DA. Spontaneous regression in non-Hodgkin's lymphoma. Cancer1980 ; 45 : 2627 \u201332.","DOI":"10.1002\/1097-0142(19800515)45:10<2627::AID-CNCR2820451023>3.0.CO;2-0"},{"key":"key\n\t\t\t\t20171012211941_BIB4","unstructured":"van Oers MH, Klasa R, Marcus RE, Wolf M, Kimby E, Gascoyne RD, et al. Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin's lymphoma, both in patients with and without rituximab during induction: results of a prospective randomized phase III intergroup trial. Blood 2006 . Available at: http:\/\/www.bloodjournal.org\/cgi\/reprint\/blood-2006-05-021113v1 . [July 27 Epub ahead of print.]"},{"key":"key\n\t\t\t\t20171012211941_BIB5","doi-asserted-by":"crossref","unstructured":"Lynch RG, Graff RJ, Sirisinha S, Simms ES, Eisen HN. Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci U S A1972 ; 69 : 1540 \u20134.","DOI":"10.1073\/pnas.69.6.1540"},{"key":"key\n\t\t\t\t20171012211941_BIB6","doi-asserted-by":"crossref","unstructured":"Levy R, Dilley J. Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization. Proc Natl Acad Sci U S A1978 ; 75 : 2411 \u20135.","DOI":"10.1073\/pnas.75.5.2411"},{"key":"key\n\t\t\t\t20171012211941_BIB7","doi-asserted-by":"crossref","unstructured":"Miller RA, Maloney DG, Warnke R, Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med1982 ; 306 : 517 \u201322.","DOI":"10.1056\/NEJM198203043060906"},{"key":"key\n\t\t\t\t20171012211941_BIB8","doi-asserted-by":"crossref","unstructured":"Raffeld M, Neckers L, Longo DL, Cossman J. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype. N Engl J Med1985 ; 312 : 1653 \u20138.","DOI":"10.1056\/NEJM198506273122601"},{"key":"key\n\t\t\t\t20171012211941_BIB9","doi-asserted-by":"crossref","unstructured":"Meeker T, Lowder J, Cleary ML, Stewart S, Warnke R, Sklar J, et al. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med1985 ; 312 : 1658 \u201365.","DOI":"10.1056\/NEJM198506273122602"},{"key":"key\n\t\t\t\t20171012211941_BIB10","doi-asserted-by":"crossref","unstructured":"Campbell MJ, Carroll W, Kon S, Thielmans K, Rothbard JB, Levy S, et al. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J Immunol1987 ; 139 : 2825 \u201333.","DOI":"10.4049\/jimmunol.139.8.2825"},{"key":"key\n\t\t\t\t20171012211941_BIB11","doi-asserted-by":"crossref","unstructured":"Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med1992 ; 327 : 1209 \u201315.","DOI":"10.1056\/NEJM199210223271705"},{"key":"key\n\t\t\t\t20171012211941_BIB12","doi-asserted-by":"crossref","unstructured":"Bendandi M, Gocke CD, Kobrin CB, Benko FA, Sternas LA, Pennington R, et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med1999 ; 5 : 1171 \u20137.","DOI":"10.1038\/13928"},{"key":"key\n\t\t\t\t20171012211941_BIB13","doi-asserted-by":"crossref","unstructured":"Timmerman JM, Vose J, Levy R, Mayo M, Denney D. Long-term follow-up of patients treated in a phase 2 trial with MyVax Personalized Immunotherapy (recombinant Id-KLH with GM-CSF) after chemotherapy as initial treatment for follicular non-Hodgkin's lymphoma [abstract]. Blood2005 ; 106 : 2438 .","DOI":"10.1182\/blood.V106.11.2438.2438"},{"key":"key\n\t\t\t\t20171012211941_BIB14","doi-asserted-by":"crossref","unstructured":"Inog\u00e8s S, Rodr\u00ecguez-Calvillo M, Zabalgui N, L\u00f2pez-D\u00ecaz de Cerio A, Villanueva H, Soria E, et al. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma. J Natl Cancer Inst2006 ; 98 : 1292 \u2013301.","DOI":"10.1093\/jnci\/djj358"},{"key":"key\n\t\t\t\t20171012211941_BIB15","doi-asserted-by":"crossref","unstructured":"Johnson PW, Rohatiner AZ, Whelan JS, Price CG, Love S, Lim J, et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol1995 ; 13 : 140 \u20137.","DOI":"10.1200\/JCO.1995.13.1.140"},{"key":"key\n\t\t\t\t20171012211941_BIB16","doi-asserted-by":"crossref","unstructured":"Caspar CB, Levy S, Levy R. Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations. Blood1997 ; 90 : 3699 \u2013706.","DOI":"10.1182\/blood.V90.9.3699"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/98\/18\/1263\/7687752\/djj371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T22:37:36Z","timestamp":1683585456000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jnci\/article\/98\/18\/1263\/2521792\/Idiotype-Vaccination-in-Follicular-Lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,20]]},"references-count":16,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2006,9,20]]},"published-print":{"date-parts":[[2006,9,20]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djj371","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,9,20]]},"published":{"date-parts":[[2006,9,20]]}}}